These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11531258)

  • 1. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe.
    Tanière P; Martel-Planche G; Saurin JC; Lombard-Bohas C; Berger F; Scoazec JY; Hainaut P
    Br J Cancer; 2001 Sep; 85(5):721-6. PubMed ID: 11531258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand.
    Tanière P; Martel-Planche G; Puttawibul P; Casson A; Montesano R; Chanvitan A; Hainaut P
    Int J Cancer; 2000 Oct; 88(2):223-7. PubMed ID: 11004672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran.
    Sepehr A; Tanière P; Martel-Planche G; Zia'ee AA; Rastgar-Jazii F; Yazdanbod M; Etemad-Moghadam G; Kamangar F; Saidi F; Hainaut P
    Oncogene; 2001 Nov; 20(50):7368-74. PubMed ID: 11704866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
    Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
    Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
    Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R
    J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer.
    Hill KA; Wang KL; Stryker SJ; Gupta R; Weinrach DM; Rao MS
    Oncol Rep; 2004 May; 11(5):951-6. PubMed ID: 15069531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Liberski PP
    Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H; Kristensen GB; Lie AK; Holm R
    Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
    Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
    Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
    Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
    Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
    Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
    Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.
    Lu ML; Wikman F; Orntoft TF; Charytonowicz E; Rabbani F; Zhang Z; Dalbagni G; Pohar KS; Yu G; Cordon-Cardo C
    Clin Cancer Res; 2002 Jan; 8(1):171-9. PubMed ID: 11801555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
    Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
    Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
    Nylander K; Dabelsteen E; Hall PA
    J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.
    Sturm I; Petrowsky H; Volz R; Lorenz M; Radetzki S; Hillebrand T; Wolff G; Hauptmann S; Dörken B; Daniel PT
    J Clin Oncol; 2001 Apr; 19(8):2272-81. PubMed ID: 11304781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.